期刊文献+

肝细胞性肝癌组织浸润淋巴细胞表型与分布研究 被引量:3

Phenotype and distribution of infiltrating lymphocytes in liver cancer tissues
下载PDF
导出
摘要 目的:肝细胞性肝癌组织浸润淋巴细胞与外周血T细胞表型可能与肿瘤进展及预后相关,本研究检测肝癌患者组织及外周血T细胞表型与分布,分析淋巴细胞表型变化与预后的关系。方法:分析2007年10月至12月中山医院147例肝癌及癌旁组织浸润淋巴细胞表型(T细胞或B细胞表面标志物:CD3、CD8、CD4、CD20、CD19、Foxp3),表型与临床病理特征及预后的关系;检测26例肝癌外周血CD3、CD8、CD4+T细胞数量并其比例变化。结果:癌巢内肿瘤浸润细胞明显少于癌周组织(P<0.01),癌周淋巴细胞主要分布于癌旁正常肝组织、汇管区,其与患者肝炎病史及肝硬化相关,表型以CD3+T细胞为主,其中又以CD8+细胞毒性T细胞为主;CD4染色在多数病例为阴性,Foxp3仅在个别病例(15/109)呈阳性。肿瘤浸润淋巴细胞B细胞标志CD20、CD19均为阴性。肿瘤组织内CD8+T细胞浸润数量与预后正相关,而癌周浸润淋巴细胞数目与患者转移及复发无显著关系。结论:肝癌肿瘤浸润细胞在癌巢内明显少于癌周组织,肿瘤及癌周浸润细胞以CD8+细胞毒性T细胞为主。肿瘤组织内CD8+T细胞浸润数量与预后相关,而癌周浸润淋巴细胞数量与患者转移及复发无显著关系。 Objective: To identify the signature of tumor-infiltrating lymphocyte (TIL) subtypes that may affect cytokine expres- sion between different outcomes of hepatocellular carcinoma (HCC) patients by analyzing the CD molecular expression profiles of non- cancerous hepatic tissues. Methods: Surface markers of TIL in noncancerous hepatic tissues from 146 HCC patients were determined by using immunohistochemical method and flow cytometry. Univariate and multivariate Cox proportional hazards models and Kaplan- Meier method were used to analyze the association of their expression levels with tumor recurrence and survival. Results: More than 86.4% of TILs in patients were quiescent, as measured via CD4+ or Foxp3 expression. Meanwhile, more than 90% of CD3+T cells ex- pressed CDS+. The proportion of T cells was low compared with CDS+ T cells. The proportion of CD 19 and CD20 in distant nontumor tissues almost was zero. The proportion of T cell subgroups isolated from HCC circulating whole blood did not show a significant shift compared with the normal control, as follows: CD4+T/CDS+T = 1.167 ± 1.04, CDS+ T/CD3+T = 0.288 ± 0.116, and CD4+T/CD3+T = 0.429 ± 0.178. The proportion of CDS+T cells in noncancerous hepatic tissues was higher than that in blood (P〈0.001).Conclusion: TILs in HCC noncancerous hepatic tissues are increased and contain a subpopulation of CD3+CD8+T cells. CDS+T cells in cancerous tissues, rather than noncancerous tissues, show significant differences between different prognostic groups.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2015年第11期559-563,共5页 Chinese Journal of Clinical Oncology
关键词 肿瘤浸润淋巴细胞 肝癌 表型 预后 tumor-infiltrating lymphocyte, hepatocellular carcinoma, phenotype, prognosis
  • 相关文献

参考文献12

  • 1Wu HC,Wang Q,Yang HI,et al.Aflatoxin B1 exposure,hepatitis B virus infection,and hepatocellular carcinoma in Taiwan[J].Cancer Epidemiol Biomarkers Prev,2009,18(3):846-853.
  • 2Chemin I,Zoulim F.Hepatitis B virus induced hepatocellular carcinoma[J].Cancer Lett,2009,286(1):52-59.
  • 3Yuen MF,Wong DK,Fung J,et al.HBs Ag Seroclearance in chronic hepatitis B in Asian patients:replicative level and risk of hepatocellular carcinoma[J].Gastroenterology,2008,135(4):1192-1199.
  • 4Unitt E,Rushbrook SM,Marshall A,et al.Compromised lymphocytes infiltrate hepatocellular carcinoma:the role of T-regulatory cells[J].Hepatology,2005,41(4):722-730.
  • 5Guo CL,Yang HC,Yang XH,et al.Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma[J].Asian Pac J Cancer Prev,2012,13(11):5909-5913.
  • 6Kobayashi N,Hiraoka N,Yamagami W,et al.FOXP3+regulatory T cells affect the development and progression of hepatocarcinogenesis[J].Clin Cancer Res,2007,13(3):902-911.
  • 7An JL,Ji QH,An JJ,et al.Clinicopathological analysis of CD8-positive lymphocytes in the tumor parenchyma and stroma of hepatocellular carcinoma[J].Oncol Lett,2014,8(5):2284-2290.
  • 8Sasaki A,Tanaka F,Mimori K,et al.Prognostic value of tumorinfiltrating FOXP3+regulatory T cells in patients with hepatocellular carcinoma[J].Eur J Surg Oncol,2008,34(2):173-179.
  • 9Unitt E,Marshall A,Gelson W,et al.Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation[J].J Hepatol,2006,45(2):246-253.
  • 10Kalathil S,Lugade AA,Miller A,et al.Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+)T regulatory cells and myeloidderived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality[J].Cancer Res,2013,73(8):2435-2444.

同被引文献22

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部